Search results for "Insurance"

showing 10 items of 194 documents

Comparison of rehospitalization rates in France and the United States

2014

Objective To compare rates of 30-day all-cause rehospitalization in France and the US among patients aged 65 years and older and explain any difference between the countries. Methods To calculate rehospitalization rates in France, we use an individual identifying variable in the national hospital administrative dataset to track unique individuals aged 65 years or more hospitalized in France in 2010. To calculate the proportion of rehospitalized patients (65+) who received outpatient visits between the time of initial discharge and rehospitalization, we linked the hospital database with a database that includes all medical and surgical admissions. We used step by step regression models to pr…

MalePopulationComorbidityPrimary carePatient ReadmissionSeverity of Illness IndexInsurance Claim ReviewSex FactorsAmbulatory CaremedicineHumanseducationHealth policyAgedAged 80 and overeducation.field_of_studybusiness.industryHealth PolicyAge FactorsPublic Health Environmental and Occupational HealthMedicare beneficiarymedicine.diseaseUnited StatesOutpatient visitsFemaleFranceHealth Services ResearchMedical emergencyNursing homesbusinessDemographyJournal of Health Services Research & Policy
researchProduct

Risk of Stroke and Post-Stroke Adverse Events in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease

2017

Background The risk and outcomes of stroke in patients with chronic obstructive pulmonary disease exacerbations (COPDe) remain unclear. We examined whether patients with COPDe faced increased risk of stroke or post-stroke outcomes. Methods Using Taiwan’s National Health Insurance Research Database, we identified 1918 adults with COPDe and selected comparison cohorts of 3836 adults with COPD no exacerbations and 7672 adults without COPD who were frequency matched by age and sex in 2000–2008 (Study 1). Stroke event was identified during 2000–2013 follow-up period. Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) of stroke associated with COPDe were calculated. In a nested cohor…

MalePulmonologyEconomicslcsh:MedicineSocial SciencesComorbidityVascular MedicinePulmonary Disease Chronic Obstructive0302 clinical medicineRisk FactorsMedicine and Health SciencesOdds Ratio030212 general & internal medicinelcsh:ScienceStrokeAged 80 and overCOPDMultidisciplinaryHazard ratioMiddle AgedStrokeHospitalizationNeurologyResearch DesignPopulation SurveillanceDisease ProgressionFemaleCohort studyResearch ArticleAdultmedicine.medical_specialtyClinical Research DesignChronic Obstructive Pulmonary DiseaseCerebrovascular DiseasesCardiologyTaiwanResearch and Analysis MethodsRisk Assessment03 medical and health sciencesHealth EconomicsInternal medicinemedicineHumansIntensive care medicineAdverse effectIschemic StrokeAgedRetrospective StudiesEpilepsybusiness.industrylcsh:RRetrospective cohort studyOdds ratioPneumoniamedicine.diseaseComorbidityrespiratory tract diseasesHealth CarePatient Outcome Assessment030228 respiratory systemlcsh:QAdverse EventsbusinessHealth InsurancePLoS ONE
researchProduct

The financial burden of non-communicable chronic diseases in rural Nigeria: Wealth and gender heterogeneity in health care utilization and health exp…

2016

Objectives Better insights into health care utilization and out-of-pocket expenditures for non-communicable chronic diseases (NCCD) are needed to develop accessible health care and limit the increasing financial burden of NCCDs in Sub-Saharan Africa. Methods A household survey was conducted in rural Kwara State, Nigeria, among 5,761 individuals. Data were obtained using biomedical and socio-economic questionnaires. Health care utilization, NCCD-related health expenditures and distances to health care providers were compared by sex and by wealth quintile, and a Heckman regression model was used to estimate health expenditures taking selection bias in health care utilization into account. Res…

MaleRural PopulationEconomicsHealth Care ProvidersHBSocial Scienceslcsh:MedicineTransportationHealth Services AccessibilityGeographical LocationsHousehold survey0302 clinical medicineCost of IllnessRA0421Surveys and QuestionnairesHealth carePrevalenceMedicine and Health SciencesMedicinePublic and Occupational Health030212 general & internal medicine10. No inequalityChildlcsh:Sciencemedia_commonFamily CharacteristicsMultidisciplinary030503 health policy & services1. No povertyMiddle AgedSocioeconomic Aspects of Health3. Good healthPeer reviewChild PreschoolSDG 1 - No PovertyEngineering and Technology/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemale0305 other medical science/dk/atira/pure/sustainabledevelopmentgoals/no_povertyResearch ArticleAdultFinancing PersonalAdolescentmedia_common.quotation_subjectQuality careNigeria03 medical and health sciencesYoung AdultHealth EconomicsSDG 3 - Good Health and Well-beingHumansAgedSelection biasFinanceConsumption (economics)Health economicsbusiness.industrylcsh:RInfant NewbornInfantTargeted interventionsPatient Acceptance of Health CareHealth CareCross-Sectional StudiesHealth Care FacilitiesChronic DiseasePeople and PlacesAfricalcsh:QHealth ExpendituresbusinessFinanceHealth Insurance
researchProduct

How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010–2016

2020

Purpose. To describe intravitreal anti-VEGF drug and dexamethasone use in four Italian regions. Methods. Four regional claims databases were used to measure drug prevalence, compare dosing intervals to those recommended in the summary of product characteristics (SPC), and identify switchers. Bilateral treatment and diabetic macular edema (DME) coding algorithms were validated, linking claims with a sample of prospectively collected ophthalmological data. Results. Overall, 41,836 patients received ≥1 study drug in 2010–2016 (4.8 per 10,000 persons). In 2016, anti-VEGF drug use ranged from 0.8 (Basilicata) to 5.7 (Lombardy) per 10,000 persons while intravitreal dexamethasone use ranged from 0…

MaleVascular Endothelial Growth Factor A0301 basic medicineintravitrealAngiogenesis Inhibitorsalgorithm.0302 clinical medicineMedicineSummary of Product Characteristicsmedia_commonAged 80 and overDrug ImplantsvalidationLaser CoagulationRGeneral MedicineMiddle AgedItalyanti-VEGF030220 oncology & carcinogenesisMedicineFemaleclinical dataoriginal articleResearch Articlemedicine.drugDrugmedicine.medical_specialtyArticle Subjectmedia_common.quotation_subjectMEDLINEdexamethasonePharmacyMacular EdemaGeneral Biochemistry Genetics and Molecular BiologyInsurance Claim Review03 medical and health sciencesRanibizumabInternal medicineHumansDosingDexamethasoneAgedDiabetic RetinopathyGeneral Immunology and MicrobiologySettore MED/30 - Malattie Apparato Visivobusiness.industryclaims database030104 developmental biologydrug utilisationMacular Edema; Ranibizumab; Laser CoagulationImplantRanibizumabbusinessBioMed Research International
researchProduct

Clinical and financial analysis of an acute palliative care unit in an oncological department

2008

The aim of this article is to describe the clinical activity and medical intervention of an acute model of palliative care unit (APC), as well as the reimbursement procedures and economic viability. A sample of 504 patients admitted at an APC in 1 year was surveyed. Indications for admission, pain and symptom intensity, analgesic treatments, procedures, instrumental examinations and modalities of discharge were recorded. For each patient, tariff for reimbursement was calculated according to the existent disease related grouping (DRG) system. The mean age was 62 years, and 246 patients were males. The mean hospital stay was 5.4 days. Pain control was the most frequent indication for admissi…

Malemedicine.medical_specialtyPalliative carePainSettore MED/42 - Igiene Generale E ApplicataUnit (housing)Economic viabilityIntervention (counseling)NeoplasmscostmedicineFinancial analysisTerminal careHumansProspective StudiesIntensive care medicinepain and symptom controlReimbursementCancerTerminal Carepalliative carebusiness.industryDelivery of Health Care IntegratedGeneral MedicineMiddle AgedAnalgesics OpioidAnesthesiology and Pain MedicineTreatment OutcomeItalyEmergency medicineInsurance Health ReimbursementFemaleOpioid analgesicsbusinessErythrocyte TransfusionDelivery of Health Care
researchProduct

Epidemiology of urticaria in German children

2020

Background To date, robust epidemiological metrics as well as data on comorbidity in pediatric urticaria are lacking. They form the basis for the design of efficient healthcare. Methods Retrospective study to analyze epidemiological data in pediatric urticaria. The analysis is based on routine data of a health insurance company operating throughout Germany (DAK-Gesundheit). Insured people under 18 years of age who received at least one confirmed outpatient or inpatient urticaria diagnosis according to the ICD-10 classification in the years 2010 to 2015 were included in the analysis and compared to children without a corresponding diagnosis. Results Of 2.3 million insured individuals, 313,58…

Malemedicine.medical_specialtyPediatricsAdolescentUrticaria610 MedizinMEDLINEComorbidityDermatology030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineimmune system diseases610 Medical sciencesHealth careEpidemiologyPrevalenceHealth insuranceHumansMedicineChildskin and connective tissue diseasesRetrospective Studiesbusiness.industryRetrospective cohort studymedicine.diseaseComorbidityObesityMental healthFemalebusinessDelivery of Health CareJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Impact of an ambulatory physical activity program on balance and motor abilities of retirees: a prospective study

2020

International audience; BACKGROUND:Given the public health problem generated by posture and gait disorders, a preventive approach is essential.OBJECTIVE:We investigated the impact of an ambulatory physical activity program (APAP) on the motor skills of retirees.METHOD:Retirees ≥ 60 years were recruited in this prospective study. The APAP was supported by a French regional health insurance plan. Between inclusion (T0) and 12 weeks (T1), subjects participated in an APAP (1 hour/week) that included strengthening muscular exercises, balance work, joint flexibility exercises, one-leg-balance test (OLB), stimulation of the foot arch, and rise-from-the-floor (RFF). Timed-up-and-go test (TUG) durat…

Malemedicine.medical_specialtyPhysical activityHealth PromotionMotor Activity030204 cardiovascular system & hematologyelderlyAmbulatory Care Facilities03 medical and health sciences0302 clinical medicineQuality of lifemedicineHumansProspective Studies030212 general & internal medicineProspective cohort studyHealth insurance planGaitPostural BalanceMotor skillAgedBalance (ability)Aged 80 and overbusiness.industryphysical exercisesbalanceGeneral MedicineMiddle AgedGaitExercise Therapy3. Good healthTime and Motion StudiesAmbulatoryPhysical therapy[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]FemalebusinessInternational Journal of Clinical Practice
researchProduct

Learning and the Price Dynamics of a Double-Auction Financial Market with Portfolio Traders

2006

In this paper we study the dynamics of price adjustments in an artificial market where portfolio traders with bounded rationality and limited resources interact through a continuous, electronic open book. The present work extends the model developed in [? ] introducing endogenous target individual portfolio holdings. We model the agents’ order-flow investment decision as an optimal choice given individual characteristics and the available information. We depart from the standard asset pricing framework in two ways. First, we assume that investors have imperfect information about the returns distribution. In particular, we assume that agents hold arbitrary priors about securities’ returns, w…

Mark to modelMarket depthCapital market lineFinancial economicsPortfolio insuranceReplicating portfolioEconometricsCapital asset pricing modelPortfolioAsset allocationBusinessRisky AssetPrice Dynamics Asset Return Limit Order Tail Dependence
researchProduct

New Challenges of Economic and Business Development – 2012 : Conference Proceedings (May 10 - 12, 2012, Riga, University of Latvia)

2012

Support for Conference Proceedings by ERAF Project "Support for the international cooperation projects and other international cooperation activities in research and technology at the University of Latvia" No. 2010/0202/2DP/2.1.1.2.0/10/APIA/VIAA/013

Market efficiencyInternational franchisingTriple Helix modelOptimal capital structureLogisticsGDPTeam PerformanceManagement theoryTourismAirline industryStakeholdersInsurance marketsNew Product DevelopmentRisksHuman capitalMunicipality budgetMarketingDevelopment economicsResearch policyCost-benefit analysisBusiness groupsOrganizational developmentMergers and acquisitionsInternational rating agencyCompliance Management SystemsRegional integrationKnowledge sharingFinancial scienceWell-beingBargain purchaseTax wedgeFinancial managementEducationEmployee selectionMonetary policyCorporate cultureHigher educationCitizen participationInnovationMotivationOnline surveysManagement educationEmployer BrandingBrand imageFinancial analysisInternal auditPrint advertisement assessmentICT:SOCIAL SCIENCES::Business and economics [Research Subject Categories]Environmental management accountingFinancial system stabilityEmployee satisfactionBanking sectorSocial MediaPension system
researchProduct

A Conditional Value–at–Risk Model for Insurance Products with Guarantee

2009

We propose a model to select the optimal portfolio which underlies insurance policies with a guarantee. The objective function is defined in order to minimise the conditional value at-risk (CVaR) of the distribution of the losses with respect to a target return. We add operational and regulatory constraints to make the model as flexible as possible when used for real applications. We show that the integration of the asset and liability side yields superior performances with respect to naive fixed-mix portfolios and asset based strategies. We validate the model on out-of-sample scenarios and provide insights on policy design.

Mathematical optimizationPortfolio selection.Actuarial scienceComputer scienceCVARAsset-liability managementAsset-liability management; Conditional value-at-risk; CVaR; Policies with a minimum guarantee; Portfolio selection.Management Science and Operations ResearchPolicies with a minimum guaranteeExpected shortfallInsurance policyReplicating portfolioPortfolioCapital asset pricing modelAsset (economics)Statistics Probability and UncertaintyBusiness and International ManagementPortfolio optimizationCVaRConditional value-at-risk
researchProduct